Are you Dr. Hobbs?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 93 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
5323 Harry Hines Blvd
Dallas, TX 75390Phone+1 214-645-2868Fax+1 214-648-1666
Summary
- Dr. Helen Hobbs, MD is a medical geneticist in Dallas, Texas. She is currently licensed to practice medicine in Texas. She is affiliated with University of Texas Southwestern Medical Center and is a Professor of Medicine at University Tex SW Dallas.
Education & Training
- University of Texas Southwestern Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1983 - 1986
- University of Texas Southwestern Medical CenterResidency, Internal Medicine, 1980 - 1983
- New York Presbyterian Hospital (Columbia Campus)Internship, Internal Medicine, 1979 - 1980
- Case Western Reserve University School of MedicineClass of 1979
Certifications & Licensure
- TX State Medical License 1982 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Elected Member Institute of Medicine, 2004
- Elected Member The American Society for Clinical Investigation, 1991
- Join now to see all
Clinical Trials
- Dallas Heart Study 2: Return Clinic Visit for the Dallas Heart Study Cohort Start of enrollment: 2007 Sep 01
- Comparison of Efficacy and Safety of Ezetimibe or Statin Monotherapy to Co-Administration of Both Start of enrollment: 2005 Feb 01
Publications & Presentations
PubMed
- 2 citationsPNPLA3(148M) is a gain-of-function mutation that promotes hepatic steatosis by inhibiting ATGL-mediated triglyceride hydrolysis.Yang Wang, Sen Hong, Hannah Hudson, Nora Kory, Lisa N Kinch
Journal of Hepatology. 2024-11-15 - 4 citationsThe ubiquitin E3 ligase BFAR promotes degradation of PNPLA3.Avash Das, Haili Cheng, Yang Wang, Lisa N Kinch, Guosheng Liang
Proceedings of the National Academy of Sciences of the United States of America. 2024-02-06 - 2 citationsPCSK9: From Nature's Loss to Patient's Gain.Helen H Hobbs, Jonathan C Cohen, Jay D Horton
Circulation. 2024-01-16
Press Mentions
- A Powerhouse of Obesity Research – Then and NowSeptember 20th, 2024
- Bringing Together Science and the Lived Experience at Family Heart Global SummitAugust 21st, 2024
- UT Southwestern Pharmacologist Named Howard Hughes Medical Institute InvestigatorJuly 23rd, 2024
- Join now to see all
Grant Support
- Role Of ABCG5 And ABCG8 In Sterol MetabolismNational Heart, Lung, And Blood Institute2008–2012
- Role Of PNPLA3 In Fatty Liver DiseaseNational Institute Of Diabetes And Digestive And Kidney Diseases2011
- Genetic Approaches To Cholesterol Metabolism In HumansNational Heart, Lung, And Blood Institute2002–2011
- Expression Profiling Of Cellular Metabolism Using Massively Parallel SequencingNational Center For Research Resources2010
- The PCSK9 Gene: Relationship To Human HealthNational Center For Research Resources2007
- The Genetics Of Cholesterol AbsorptionNational Center For Research Resources2007
- Metabolic And Genetic Basis Of Bare Sterol DisordersNational Center For Research Resources2007
- Role Of ABCG5 And ABCG8 In Sterol MetabolismNational Heart, Lung, And Blood Institute2003–2007
- Metabolic And Genetic Basis Of RARE Sterol DisordersNational Center For Research Resources2006
- Genetic Approaches To Cholestrol Metabolism In Human SubjectNational Heart, Lung, And Blood Institute2004–2006
- Genetic Determinants Of Plasma Lp(A) ConcentrationNational Heart, Lung, And Blood Institute1995–2004
- Institutional Training Grant In Genomic ScienceNational Human Genome Research Institute1999
- Genetic Determinants Of Plasma LP (A) ConcentrationNational Heart, Lung, And Blood Institute1992–1994